BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 23540693)

  • 21. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.
    Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW
    Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retroviral insertional mutagenesis in telomerase-immortalized hepatocytes identifies RIPK4 as novel tumor suppressor in human hepatocarcinogenesis.
    Heim D; Cornils K; Schulze K; Fehse B; Lohse AW; Brümmendorf TH; Wege H
    Oncogene; 2015 Jan; 34(3):364-72. PubMed ID: 24413083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Copper Sulfate on Expression of Endogenous L1 Retrotransposons in HepG2 Cells (Hepatocellular Carcinoma).
    Karimi A; Majidzadeh-A K; Madjd Z; Akbari A; Habibi L; Akrami SM
    Biol Trace Elem Res; 2015 Jun; 165(2):131-4. PubMed ID: 25663478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic and epigenetic alterations of the KLF6 gene in hepatocellular carcinoma.
    Song J; Kim CJ; Cho YG; Kim SY; Nam SW; Lee SH; Yoo NJ; Lee JY; Park WS
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1286-9. PubMed ID: 16872311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker.
    Lui KY; Zhao H; Qiu C; Li C; Zhang Z; Peng H; Fu R; Chen HA; Lu MQ
    BMC Cancer; 2017 Sep; 17(1):644. PubMed ID: 28899352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA variants of DLC-1, a candidate tumor suppressor gene in human hepatocellular carcinoma.
    Park SW; Durkin ME; Thorgeirsson SS; Popescu NC
    Int J Oncol; 2003 Jul; 23(1):133-7. PubMed ID: 12792785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
    Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
    J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. L1 retrotransposition in neurons is modulated by MeCP2.
    Muotri AR; Marchetto MC; Coufal NG; Oefner R; Yeo G; Nakashima K; Gage FH
    Nature; 2010 Nov; 468(7322):443-6. PubMed ID: 21085180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex bias occurrence of hepatocellular carcinoma in Poly7 molecular subclass is associated with EGFR.
    Keng VW; Sia D; Sarver AL; Tschida BR; Fan D; Alsinet C; Solé M; Lee WL; Kuka TP; Moriarity BS; Villanueva A; Dupuy AJ; Riordan JD; Bell JB; Silverstein KA; Llovet JM; Largaespada DA
    Hepatology; 2013 Jan; 57(1):120-30. PubMed ID: 22899566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA CASC2c inhibited cell proliferation in hepatocellular carcinoma by inactivated ERK1/2 and Wnt/β-catenin signaling pathway.
    Li QY; Yang K; Liu FG; Sun XG; Chen L; Xiu H; Liu XS
    Clin Transl Oncol; 2020 Mar; 22(3):302-310. PubMed ID: 31625123
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Ho DWH; Chan LK; Chiu YT; Xu IMJ; Poon RTP; Cheung TT; Tang CN; Tang VWL; Lo ILO; Lam PWY; Yau DTW; Li MX; Wong CM; Ng IOL
    Gut; 2017 Aug; 66(8):1496-1506. PubMed ID: 27974549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic expression of ZNF382 and its tumor-suppressor role in hepatitis B virus-related hepatocellular carcinogenesis.
    Dang S; Zhou J; Chen Y; Chen P; Ji M; Shi B; Yang Q; Hou P
    Oncogene; 2019 Jun; 38(24):4804-4819. PubMed ID: 30804458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesis.
    Lee YY; Mok MT; Kang W; Yang W; Tang W; Wu F; Xu L; Yan M; Yu Z; Lee SD; Tong JHM; Cheung YS; Lai PBS; Yu DY; Wang Q; Wong GLH; Chan AM; Yip KY; To KF; Cheng ASL
    Nucleic Acids Res; 2018 Sep; 46(17):8832-8847. PubMed ID: 29992318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The RNA polymerase dictates ORF1 requirement and timing of LINE and SINE retrotransposition.
    Kroutter EN; Belancio VP; Wagstaff BJ; Roy-Engel AM
    PLoS Genet; 2009 Apr; 5(4):e1000458. PubMed ID: 19390602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing β-catenin expression and nuclear translocation.
    Liu Y; Ye X; Zhang JB; Ouyang H; Shen Z; Wu Y; Wang W; Wu J; Tao S; Yang X; Qiao K; Zhang J; Liu J; Fu Q; Xie Y
    Oncogene; 2015 Oct; 34(44):5524-35. PubMed ID: 25684142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.
    Ye J; Liang R; Bai T; Lin Y; Mai R; Wei M; Ye X; Li L; Wu F
    J Exp Clin Cancer Res; 2018 Sep; 37(1):212. PubMed ID: 30176896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ionising irradiation alters the dynamics of human long interspersed nuclear elements 1 (LINE1) retrotransposon.
    Tanaka A; Nakatani Y; Hamada N; Jinno-Oue A; Shimizu N; Wada S; Funayama T; Mori T; Islam S; Hoque SA; Shinagawa M; Ohtsuki T; Kobayashi Y; Hoshino H
    Mutagenesis; 2012 Sep; 27(5):599-607. PubMed ID: 22547343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sleeping Beauty insertional mutagenesis screen identifies the pro-metastatic roles of CNPY2 and ACTN2 in hepatocellular carcinoma tumor progression.
    Lo LH; Lam CY; To JC; Chiu CH; Keng VW
    Biochem Biophys Res Commun; 2021 Feb; 541():70-77. PubMed ID: 33482578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation analysis of the 8p22 candidate tumor suppressor gene ATIP/MTUS1 in hepatocellular carcinoma.
    Di Benedetto M; Pineau P; Nouet S; Berhouet S; Seitz I; Louis S; Dejean A; Couraud PO; Strosberg AD; Stoppa-Lyonnet D; Nahmias C
    Mol Cell Endocrinol; 2006 Jun; 252(1-2):207-15. PubMed ID: 16650523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.